A pilot open label phase I trial to evaluate the safety and the tolerability of a combination of two HIV-1 inducers in HIV+ sub-type B patients under cART with undetectable viral load

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518141-13-00

Acronym

ANRS 171 SYNACTHIV

Enrollment

Registered

2024-10-16

Start date

2022-12-05

Completion date

Unknown

Last updated

2024-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

None listed

Sex/Gender

Male

Age

18 Years to No maximum

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026